CDT Equity Inc.
CDTNASDAQHealthcare● Active
$0.78
+$0.04(+5.30%)
Market Cap$3765221
P/E Ratio—
52W High$610
52W Low$0.6859
CDT Equity Inc. (CDT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDT · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$13.10
Revenue
$0.70B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
CDT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 30, 2026 | — | $13.10 | — | $0.70B | — | — |
| — Q2 FY2026 | Apr 3, 2026 | — | -$99.99 | — | — | — | — |
| — Q4 FY2025 | Nov 13, 2025 | — | -$13.16 | — | — | — | — |
| — Q3 FY2025 | Aug 14, 2025 | — | -$43.68 | — | — | — | — |
| — Q2 FY2025 | May 15, 2025 | — | -$158.32 | — | — | — | — |
| — Q1 FY2025 | Mar 28, 2025 | — | -$2438.38 | — | — | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$839.58 | — | — | — | — |
| — Q3 FY2024 | Aug 12, 2024 | — | -$839.58 | — | — | — | — |
Q2 FY2026
Apr 30, 2026
EPS Actual
$13.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.70B
Q2 FY2026
Apr 3, 2026
EPS Actual
-$99.99
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 13, 2025
EPS Actual
-$13.16
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 14, 2025
EPS Actual
-$43.68
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 15, 2025
EPS Actual
-$158.32
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
-$2438.38
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 14, 2024
EPS Actual
-$839.58
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 12, 2024
EPS Actual
-$839.58
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for CDT.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 30, 2026 | — | $2.25 | $2.33 | +3.56% |
| — Q2 FY2026 | Apr 3, 2026 | — | $3.95 | $3.95 | +0.00% |
| — Q4 FY2025 | Nov 13, 2025 | — | $62.25 | $57.75 | -7.23% |
| — Q3 FY2025 | Aug 14, 2025 | — | $364.00 | $334.00 | -8.24% |
| — Q2 FY2025 | May 15, 2025 | — | $1,200.00 | $1,224.00 | +2.00% |
| — Q1 FY2025 | Mar 28, 2025 | — | $2,304.00 | $2,670.00 | +15.89% |
| — Q4 FY2024 | Nov 14, 2024 | — | $28,560.29 | $28,170.28 | -1.37% |
| — Q3 FY2024 | Aug 12, 2024 | — | $57,000.57 | $51,000.51 | -10.53% |
Q2 FY2026+3.56%
Report Date
Apr 30, 2026
EPS Beat/Miss
—
Price Before
$2.25
Price After
$2.33
Q2 FY2026+0.00%
Report Date
Apr 3, 2026
EPS Beat/Miss
—
Price Before
$3.95
Price After
$3.95
Q4 FY2025-7.23%
Report Date
Nov 13, 2025
EPS Beat/Miss
—
Price Before
$62.25
Price After
$57.75
Q3 FY2025-8.24%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$364.00
Price After
$334.00
Q2 FY2025+2.00%
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
$1,200.00
Price After
$1,224.00
Q1 FY2025+15.89%
Report Date
Mar 28, 2025
EPS Beat/Miss
—
Price Before
$2,304.00
Price After
$2,670.00
Q4 FY2024-1.37%
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$28,560.29
Price After
$28,170.28
Q3 FY2024-10.53%
Report Date
Aug 12, 2024
EPS Beat/Miss
—
Price Before
$57,000.57
Price After
$51,000.51
Beat Rate0 / 8 quarters
Largest Move+15.89% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDT ends December
CDT Equity Inc. (CDT) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $13.10 (in line with the analyst consensus of —). The next CDT earnings date is expected around September 1, 2026.
Each quarter, investors track CDT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDT earnings · 4 questionsCDT Equity Inc.'s next earnings report is expected around September 1, 2026. CDT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDT historically reports after market close (AMC).
CDT earnings datewhen is CDT earningsCDT next earnings datewhen does CDT report earningsCDT earnings calendar
▸ Source: FMP · CDT Equity Inc. SEC filings · US GAAP · CDT Equity Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026